Join us on Tuesday, 23 February, at 10.00 Irish time for a webinar with Adam Kostyal Kostyál, SVP and Head of Listings EMEA, Nasdaq. Click on the Eventbrite link below to register.
Fóla Partners
Financial Services
Dublin, Wicklow 351 followers
Fóla – raising growth capital for Irish companies from Swedish and Irish investors.
About us
We are a team of experienced executives who work with Irish growth companies to raise equity and debt capital on the Nasdaq First North market through IPOs and listed Nordic Bond issues.
- Website
-
https://fola.ie/
External link for Fóla Partners
- Industry
- Financial Services
- Company size
- 2-10 employees
- Headquarters
- Dublin, Wicklow
- Type
- Privately Held
- Founded
- 2019
- Specialties
- IPO, Nordic Bonds
Locations
-
Primary
The Tree House
12 Beechurst
Dublin, Wicklow A98TW32, IE
Employees at Fóla Partners
Updates
-
Nasdaq-listed Mashup Ireland appoints Andy Byrne as CEO Mashup Ireland AB (publ) (“Mashup”), the acquisitive Irish SME investor, has announced the appointment of Andy Byrne as its new CEO, effective today 17 July 2024. Andy Byrne (49) brings a total of over three decades of experience across a wide range of relevant areas including SME start-ups, SME acquisitions, Investment banking, property investment and development, capital raising, transaction structuring and debt & equity capital markets. A member of the board since 2022, AB recently became the group’s largest shareholder with an 86.5% shareholding, and will continue as a member of the board following his appointment. As a capital starved entrepreneur for most of his life, he has a deep understanding of the challenges that Irish entrepreneurs and small business owners face. Andy has a passion for creating innovative financial solutions that was initially fostered during the 5 years that he spent as part of Merrill Lynch’s Global Product Development Team. John O Connor, who has led the company for the past 8 years is stepping down from his CEO role to focus his attention on the Kollect group of businesses which he founded in 2016 and his other successful Irish SME ventures. The Board of Directors extends its enormous gratitude to John for his dedication and leadership during his tenure as CEO which included successfully tripling the group’s revenues since taking the group public via its IPO in December 2019. "We are really pleased to welcome Andy to the CEO role," said Mary Dunphy, Chairperson of the Board. "His proven track record and visionary leadership will be invaluable as we continue to execute our strategic plans to drive growth and value for shareholders. We are confident that Andy will lead Mashup Ireland to new heights." Comment from the new CEO “I am absolutely delighted to take on the CEO role of Mashup Ireland and look forward to leading the group during its upcoming growth phase. It’s a very exciting time for the group: - Ireland has more than 350k SMEs, generating a turnover more than €420bn per annum. - Mashup is the only listed group that focuses its resources on investing and supporting Irish SMEs, entrepreneurs and business owners. I am extremely grateful for everything that John has achieved during his tenure as CEO and very much look forward to continuing working closely with him to create shareholder value going forward.” For additional information, please contact Jamie Walsh, CFO E-mail: investors@mashupireland.com Mashup Ireland AB’s Certified Adviser is Mangold #MashupIreland #IrishSMEs #Nasdaq
-
Many thanks to all the participants in our Nasdaq Listing Seminar this week including Minister Neale Richmond TD from the Department of Finance Ireland; Adam Kostyal President of Nasdaq Stockholm and Head of Listings EMEA; adviser panel members including Lorcan Colclough (Mazars in Ireland), Oskar Wollert (Carlsquare), Kevin Holmkvist (Eversheds Sutherland Sweden) and Dennis Fagerros (Nasdaq First North); and our CEO panel members including Dave Nangle of VEF, Myles Murray of PMD Solutions and John O Connor of Kollect and Andy Byrne of Mashup Group. Thanks also to everyone who attended, it was much appreciated, the support from IRELAND FOR FINANCE and the hospitality from the Stephen's Green Club. Leo Clancy, Leo McAdams, Elaine Coughlan, Patrick Flynn, Chris Burge, Johan Engström, Gary McCarthy, Jack Starling
-
Best of luck to Cathal Friel and the team at European Green Transition on their upcoming IPO on AIM.
Cathal Friel-chaired green transition firm announces London IPO plan
irishtimes.com
-
Very good interview here with Myles Murray of PMD Solutions discussing why the company listed in Sweden and why #makingeverybreathcount is so important with Johan Unnérus of Redeye AB. Johan Engström Mark Falkner (f.d. Kristoffersson) Dennis Fagerros Håkan Sjögren Adam Kostyal Sabrina Ibrisevic Niklas Blumenthal Janos Pataky Richard Goldman Leyla Ekekrantz Pontus Bäfver Petra Sas Erik Josefsson Donal MacNamee Des O'Toole Anne Dorney Martin Bailey Maria Groschopp Dellwik Magnus Vestin Doreen Burke Hannah Fraser Declan Caulfield Michael Norman Anna Olofsson Catharina Pramhäll
PMD Solutions: Interview with CEO Myles Murray
redeye.se
-
Minister of State at the Department of Finance Jennifer Carroll MacNeill TD Carroll MacNeill and Myles Murray, founder of Cork medical devices firm PMD Solutions ringing the opening bell of the Nasdaq Stockholm Exchange.
PMD begins trading on Nasdaq Nordic following reverse acquisition
irishexaminer.com
-
Great day for PMD Solutions at the Nasdaq Stockholm Exhange today.
-
Promore Pharma shareholders approve the reverse takeover by PMD Solutions, appoints a new board of directors and Myles Murray as CEO. https://lnkd.in/e9FAUkCP
report-from-the-extraordinary-general-meeting-of-promore-pharma-ab-held-on-29-december-2023.pdf
storage.mfn.se
-
Hugh congrats to Myles Murray, Anne Dorney, Tom Meagher and the team on receiving Nasdaq approval for the continued listing of the company after the reverse takeover of Promore Pharma by PMD Solutions. Fóla Partners are thankful for the opportunity to play a part in this success.
Promore Pharma AB (publ) has received approval for continued trading on Nasdaq First North Growth Market and publishes company description - ProMore Pharma | leading-edge medical innovation
promorepharma.com